Skip to main content

Table 2 Baseline characteristics, stratified by tertiles of (log)SFRP4

From: Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery disease

(log) SFRP4 Tertiles

 

1

2

3

 

(log)SFRP4 range

<0.99

0.99 - 1.11

>1.11

p-Value

Group size

33.3 (168)

33.3 (168)

33.3 (168)

 

Age (years)

65.2 ± 0.7

65.8 ± 0.8

68.2 ± 0.8

0.017

Male

86.3 (145)

85.7 (144)

78.0 (131)

0.068

Medical history

    

Previous myocardial infarction

35.7 (60)

44.6 (75)

51.8 (87)

0.014

PCI

57.1 (96)

66.7 (112)

76.8 (129)

0.001

Bypass operation

7.1 (12)

14.3 (24)

16.1 (27)

0.03

Previous stroke or TIA

6.0 (10)

12.5 (21)

13.1 (22)

0.065

Peripheral artery disease

6.5 (11)

10.1 (17)

10.7 (18)

0.37

Clinical characteristics

    

Smoking

21.4 (36)

20.8 (35)

14.3 (24)

0.18

Alcohol regularly

27.4 (46)

25.0 (42)

19.0 (32)

0.18

Positive family history

31.5 (53)

29.2 (49)

32.1 (54)

0.79

Arterial hypertension

88.7 (149)

94.0 (158)

95.2 (160)

0.095

Systolic BP (mmHg)

124.3 ± 1.2

127.0 ± 1.2

128.2 ± 1.3

0.067

Diastolic BP (mmHg)

74.0 ± 0.7

74.9 ± 0.7

74.8 ± 0.8

0.62

BMI (kg/m2)

27.9 ± 0.3

29.4 ± 0.3

29.3 ± 0.4

0.002

Waist circumference (cm)

100.9 ± 0.8

104.9 ± 0.9

104.9 ± 0.9

0.001

Waist-to-hip-ratio

1.00 ± 0.0

1.00 ± 0.0

1.01 ± 0.0

0.36

Metabolic characterization

    

Normal glucose tolerance

32.1 (54)

20.2 (34)

20.8 (35)

0.017

Impaired glucose tolerance

29.8 (50)

28.6 (48)

26.8 (45)

0.84

Diabetes mellitus

38.1 (64)

51.2 (86)

52.4 (88)

0.014

Metabolic syndrome

50.6 (85)

72.0 (121)

72.0 (121)

<0.0001

Fasting glucose (mg/dl)

118.6 ± 2.5

119.5 ± 2.3

125.0 ± 2.6

0.15

Fasting insulin (μIU/ml)

8.73 ± 0.6

11.41 ± 0.9

12.69 ± 1.1

0.007

HOMA index

2.70 ± 0.24

3.64 ± 0.36

4.33 ± 0.55

0.018

HbA1c (%)*

6.05 ± 0.1

6.09 ± 0.1

6.40 ± 0.1

0.011

Total cholesterol (mg/dl)

175.0 ± 2.8

171.2 ± 3.2

170.9 ± 3.0

0.55

HDL cholesterol (mg/dl)

46.5 ± 1.0

43.8 ± 1.0

43.8 ± 1.1

0.12

LDL cholesterol (mg/dl)

107.7 ± 2.4

105.3 ± 2.8

101.0 ± 2.6

0.19

Fasting triglycerides (mg/dl)

133.9 ± 5.3

164.6 ± 15.0

170.0 ± 9.9

0.043

Postprandial triglyerides, maximum (mg/dl)

253.5 ± 9.7

305.4 ± 19.7

309.9 ± 14.2

0.015

Postprandial triglycerides, AUC (mg/dl)

943.8 ± 36.2

1135.6 ± 68.5

1160.3 ± 54.4

0.010

C-reactive protein (mg/l)

3.65 ± 0.5

4.90 ± 0.5

4.99 ± 0.7

0.16

  1. Categorical variables are shown as rate (number) and continuous values as mean (SEM). TIA denotes transitory ischemic attack. Active smoking was regular tobacco use at or within 12 months prior to enrolment. Regular alcohol use was consumption of any alcoholic beverage >3 times/week. The HOMA (Homeostasis Model Assessment) index is the fasting glucose concentration (in milligrams per deciliter) multiplied by the fasting insulin concentration (in microunits per milliliter) divided by 405.
  2. *HbA1c was missing in 23 patients.